0
Biodesix, Inc. Banner Image

Biodesix, Inc.

  • Ticker BDSX
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
Biodesix, Inc. Logo Image
  • 51-200 Employees
  • Based in Boulder, Colorado
Biodesix is a leading data-driven diagnostic solutions company with a focus in lung disease. The Company develops diagnostic tests addressing important clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers five Medicare-covered tests for patients with lung diseases. The blood based Nodify Lung® nodule risk assessment testing strategyMore, consisting of the Nodify XL2® and the Nodify CDT® tests, evaluates the risk of malignancy in pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. The blood based IQLung™ strategy for lung cancer patients integrates the GeneStrat® targeted ddPCR™ test, the GeneStrat NGS® test and the VeriStrat® test to support treatment decisions across all stages of lung cancer with results in an average of two to three business days, expediting the time to treatment. Biodesix also leverages the proprietary and advanced Diagnostic Cortex® AI (Artificial Intelligence) platform, to collaborate with many of the world’s leading biotechnology and pharmaceutical companies to solve complex diagnostic challenges in lung disease.
Biodesix, Inc.

Most Recent Annual Report

Biodesix, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Biodesix, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!